Skip to main content

Laura Jean Havrilesky, MD

Laura Havirlesky, MD
Professor of Obstetrics and Gynecology
Campus Mail: 25172 Morris Bldg, Durham, NC 27710
Phone: (919) 684-0188
Email: havri001@mc.duke.edu

I am interested in using health economic models to inform decisions related to gynecologic cancers. Specific models have addressed the decision to administer intraperitoneal chemotherapy for newly diagnosed advanced ovarian cancer following optimal cytoreduction, the choice of chemotherapy regimen for recurrent platinum-sensitive ovarian cancer, and the exploration of screening strategies for ovarian cancer. The ovarian cancer screening model examines the effects of test cost, sensitivity, specificity, and screen frequency on ovarian cancer mortality, the lifetime false positive rate of testing, the positive predictive value of the test, and its cost effectiveness. This type of model is potentially useful in informing the design trials of novel screening tests for ovarian cancer. I am also conducting a prospective study to quantify the effects of screening for, diagnosis of, and treatment for ovarian cancer on the quality of life of women.

Education and Training

  • Residency, Obstetrics And Gynecology, Duke University, 1995 - 1999
  • M.D., Duke University, 1995

Research

I am interested in using health economic models to inform decisions related to gynecologic cancers. Specific models have addressed the decision to administer intraperitoneal chemotherapy for newly diagnosed advanced ovarian cancer following optimal cytoreduction, the choice of chemotherapy regimen for recurrent platinum-sensitive ovarian cancer, and the exploration of screening strategies for ovarian cancer.

The ovarian cancer screening model examines the effects of test cost, sensitivity, specificity, and screen frequency on ovarian cancer mortality, the lifetime false positive rate of testing, the positive predictive value of the test, and its cost effectiveness. This type of model is potentially useful in informing the design trials of novel screening tests for ovarian cancer. I am also conducting a prospective study to quantify the effects of screening for, diagnosis of, and treatment for ovarian cancer on the quality of life of women. 

Publications

Lopez-Acevedo, M, Buchanan, AH, Secord, AA, Lee, PS, Fountain, C, Myers, ER, Cohn, DE, Reed, SD, and Havrilesky, LJ. "Cost comparison among different genetic testing strategies in women with epithelial ovarian cancer." April 2015.

Full Text

Havrilesky, LJ, Dinan, M, Sfakianos, GP, Curtis, LH, Barnett, JC, Van Gorp, T, and Myers, ER. "Costs, Effectiveness, and Workload Impact of Management Strategies for Women With an Adnexal Mass." Obstetrical & Gynecological Survey 70, no. 4 (April 2015): 253-255.

Full Text

Davidson, BA, Mannschreck, DB, Broadwater, G, Lopez-Acevedo, M, Lee, PS, Havrilesky, LJ, Valea, FA, Berchuck, A, and Secord, AA. "Findings at laparoscopy, not debulking status, are associated with survival in advanced stage ovarian cancer after neoadjuvant chemotherapy." April 2015.

Full Text

Dottino, JA, Cliby, BA, Myers, ER, Bristow, RE, and Havrilesky, LJ. "Improving NCCN guideline-adherent care for ovarian cancer: Value of an intervention." April 2015.

Full Text

Ehrisman, JA, Secord, AA, Berchuck, A, Lee, PS, Di Santo, N, Valea, FA, and Havrilesky, LJ. "Sentinel lymph node mapping in women with high risk histology endometrial cancer." April 2015.

Full Text

Havrilesky, LJ, Reiner, M, Morrow, PK, Watson, H, and Crawford, J. "A review of relative dose intensity and survival in patients with metastatic solid tumors." Critical Reviews in Oncology/Hematology 93, no. 3 (March 2015): 203-210. (Review)

Full Text

Cohn, DE, Barnett, JC, Wenzel, L, Monk, BJ, Burger, RA, Straughn, JM, Myers, ER, and Havrilesky, LJ. "A cost-utility analysis of NRG Oncology/Gynecologic Oncology Group Protocol 218: Incorporating prospectively collected quality-of-life scores in an economic model of treatment of ovarian cancer." Gynecologic Oncology 136, no. 2 (February 1, 2015): 293-299.

Full Text

Cohn, DE, Barnett, JC, Wenzel, L, Monk, BJ, Burger, RA, Straughn, JM, Myers, ER, and Havrilesky, LJ. "A cost-utility analysis of NRG Oncology/Gynecologic Oncology Group Protocol 218: incorporating prospectively collected quality-of-life scores in an economic model of treatment of ovarian cancer." Gynecologic oncology 136, no. 2 (February 2015): 293-299.

Full Text

McCann, GA, Cohn, DE, Jewell, EL, and Havrilesky, LJ. "Lymphatic mapping and sentinel lymph node dissection compared to complete lymphadenectomy in the management of early-stage vulvar cancer: A cost-utility analysis." Gynecologic oncology 136, no. 2 (February 2015): 300-304.

Full Text

Teoh, D, Lowery, WJ, Jiang, X, Ehrisman, J, Halvorson, P, Broadwater, G, Bentley, R, Secord, AA, Sobolewski, C, Berchuck, A, Havrilesky, LJ, Valea, FA, and Lee, PS. "Vaginal Cuff Thermal Injury by Mode of Colpotomy at Total Laparoscopic Hysterectomy: A Randomized Clinical Trial." JOURNAL OF MINIMALLY INVASIVE GYNECOLOGY 22, no. 2 (February 2015): 227-233.

Full Text

Pages